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Abstract
Previously we demonstrated that EpH4 mouse mammary epithelial cells induced the homeobox transcription factor Msx2
either when transfected with the progesterone receptor (PR) or when treated with Bmp2/4. Msx2 upregulation was
unaffected by Wnt inhibitors s-FRP or Dkk1, but was inhibited by the Bmp antagonist Noggin. We therefore hypothesized
that PR signaling to Msx2 acts through the Bmp receptor pathway. Herein, we confirm that transcripts for Alk2/ActR1A, a
non-canonical BmpR Type I, are upregulated in mammary epithelial cells overexpressing PR (EpH4-PR). Increased
phosphorylation of Smads 1,5, 8, known substrates for Alk2 and other BmpR Type I proteins, was observed as was their
translocation to the nucleus in EpH4-PR cells. Analysis also showed that Tissue Non-Specific Alkaline Phosphatase (TNAP/
Akp2) was also found to be downregulated in EpH4-PR cells. When an Akp2 promoter-reporter construct containing a KPRE
site was transfected into EpH4-PR cells, its expression was downregulated. Moreover, siRNA mediated knockdown of Akp2
increased both Alk2 and Msx2 expression. Collectively these data suggest that PR inhibition of Akp2 results in increased Alk2
activity, increased phosphorylation of Smads 1,5,8, and ultimately upregulation of Msx2. These studies imply that re-
activation of the Akp2 gene could be helpful in downregulating aberrant Msx2 expression in PR+ breast cancers.
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Introduction
Progesterone (P) is a key regulator of mammary gland
proliferation and differentiation. The action of progesterone is
mediated by two isoforms of the progesterone receptor (PR), which
are temporally and spatially regulated during mammary develop-
ment in association with their precise functions [1]. The A isoform
(PR-A) is exclusively expressed in the virgin gland and has been
associated with ductal elongation and secondary branching, while
the B isoform (PR-B) is abundantly expressed during pregnancy
and is associated with lobuloalveolar development [2]. Transgenic
mice that overexpress PR-A demonstrate extensive lateral side-
branching at 10–14 weeks of age compared to wild type controls
[2]. Additionally, EpH4 cells are a normal mammary epithelial
cell line derived from mammary gland of a mouse in the mid-
gestation stage [3] and studies [4,5] have shown that PR is
downregulated at this stage. Previously, we showed that stable
transfection of PR-A into EpH4 mouse mammary epithelial cells
enhanced branching morphogenesis on collagen gels through
upregulation of transcription of the homeobox gene Msx2 [6].
Consistent with these results, our transgenic mice overexpressing
Msx2 in the mammary gland demonstrated extensive lateral
branching postnatally compared to wild type controls [6]. Since
there is no progesterone responsive element (PRE) on the Msx2
promoter [7], regulation must be indirect through other
transcription factors. While others have shown that P-dependent
side-branching is enhanced by Wnt 4 [8], we found no evidence
that the Wnt pathway was involved in Msx2 expression or
branching of the cells [6]. However, we did find that treating the
parental EpH4 cells with Bone Morphogenic Protein 2 (Bmp2) or
4 (Bmp4) induced both Msx2 expression and branching
morphogenesis, suggesting that a signaling cascade starting from
PR and ending with Msx2 occurred through the Bmp pathway.
Bmps were originally identified by their ability to cause bone
differentiation, but are now known to be major players in the
regulation of embryonic development and postnatal homeostasis of
various organs and tissues, by controlling cellular differentiation,
proliferation and apoptosis [9]. In the embryo, Bmp4, Msx2,
phospho-Smad 1, and Bmp receptor type 1A (BmpR1A) are co-
localized in the ventral ectoderm and collectively regulate proper
hind limb formation [10]. Msx2 has also been shown to co-localize
with the Bmps in the mouse mammary gland [11]. While our
previous study [6] showed that the Bmp pathway was involved in
induction of Msx2 in mammary cells, we found no evidence either
by RT-PCR or western blot analysis that either of the closely
related Bmp2 or 4 [11] were upregulated in the EpH4-PR cells,
which have increased Msx2 expression. Therefore, to investigate
the interactions of Bmp and PR signaling with Msx2 expression,
we examined expression of BmpR and downstream components of
the signaling pathway in the mouse mammary EpH4-PR cells.
The BmpR 1 in EpH4 cells is Alk2/ActR-1A. Alk2, as other
receptors of the TGFb superfamily, is a transmembrane receptor
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is found in the embryo [9,13] and in the developing neonate lung
[14]. Alk2, while not a canonical BmpR, binds both activin and
Bmp2/4 in conjunction with corresponding type II receptors [13].
Upon ligand binding, type II receptors phosphorylate type I
receptors in the GS domain. Type I receptors then bind and
phosphorylate the Smad proteins [15]. Smad 1, 5, and/or 8
complex with Smad 4, and migrate to the nucleus where they act
as transcription factors [12]. In association with this pathway,
Tissue Non-Specific Alkaline Phosphatase (TNAP/Akp2) has been
shown to negatively regulate Alk2 [16]. Herein, we report a
significant downregulation of Akp2 expression in the EpH4-PR
cells through PR regulation of its promoter. This downregulation
of Akp2 results in upregulation of Alk2, phosphorylation of the
Smads, and increased Msx2 expression, thereby linking PR to
Msx2 induction.
Methods
Cell Culture and Reagents
EpH4 cells, a mouse mammary epithelial cell line [17], were
transfected and clones selected as previously described [6]. EpH4-
EV or EpH4-PR cells were routinely maintained in DMEM
Growth Media (DMEM/GM) containing 10% FBS, 2 mM L-
glutamine (Invitrogen, Gaithersburg, MD), 20 mM HEPES
(Sigma, St. Louis, MO), penicillin (100 U/ml) and streptomycin
(100 mg/ml) and neomycin (G418; 400 mg/ml). For hormone or
growth factor treatment, cells were quiesced for 6 to 24 hours with
a minimal medium containing 5% charcoal stripped serum (CSS;
Gemini Bio-Products, West Sacramento, CA; DMEM/CSS).
Prior to treatment, cells were plated in 6-well dishes at a density
of 100,000 cells/ml for RNA extraction and 120,000 cells/ml for
total protein extraction. For nuclear protein experiments, cells
were plated at a density of 100,000 cells/ml in T150 flasks. Cells
were grown to approximately 70% confluence in DMEM/GM,
and then rinsed in PBS, and media changed to DMEM/CSS with
either 10
28 M progesterone (P; Sigma), Noggin (10 nM, R&D
Systems, Minneapolis, MN), Bmp2 or Bmp4 (R&D Systems,
Minneapolis, MN) at a final concentration of 300 ng/ml.
Microarrays
Microarrays were performed and analyzed as previously
described [18] by Cogenics, Inc. (Morrisville, NC) on RNA
collected from EpH4-EV or EpH4-PR cells grown in DMEM/
GM. Data was subjected to functional analysis through the use of
Ingenuity pathways analysis (IPA; Ingenuity Systems, http://www.
ingenuity.com). Microarray data with its associated MIAME
compliant data has been deposited in the public repository, Gene
Expression Omnibus, accession number GSE30637.
Semi-quantitative RT-PCR
Total RNA was extracted using TRIzol Reagent (Invitrogen),
treated with DNase (Invitrogen) to remove potential genomic
contamination, and reverse transcribed as previously described
[6]. For all PCR analyses, the number of cycles used was selected
at the linear expression level for each gene tested. PCR products
were resolved by gel electrophoresis, quantified using NIH Image J
and expressed relative to the corresponding housekeeping gene.
PCR primers used and conditions for amplification were as
outlined in Table 1A. Gene expression levels were calculated
relative to the housekeeping gene actin or GAPDH for each
experiment.
Cloning of the Akp2 promoter
The Akp2 promoter was amplified from a BAC clone (RP23-
400F8, Accession # AL807764N; Children’s Hospital Oakland
Research Institute, Oakland, CA) and PCR cloned into a pGL3
basic vector (Promega, Madison, WI) with PCR Extension kit (5
Prime, Gaithersburg, MD) at the XhoI and HindIII restriction
sites. The Akp2 promoter construct contains a K PRE site at
21495 to 21501 bp [19]. Primers (Table 1B) were used at a
300 nM final concentration using 50 ng of the BAC clone. PCR
products were resolved on a 1% agarose gel, excised, and
extracted with a MinElute Gel Extraction kit (Qiagen, Valencia,
CA). Purified products were digested with XhoI/HindIII
and ligated into pGL3 with T4 Rapid Ligation kit (Roche
Applied Science, Indianapolis, IN), purified, cloned, and sequence
verified.
Table 1. PCR primer sequences and conditions.
A. RT-PCR Primers Primer sequence (59–3 9) Anneal temp, # of cycles
Alk2 forward GGAGAAGTATGGAGGGGCAGCT 59u,3 0
Alk2 reverse GGCCCAAATATCGACCCTCTTA
Akp2 forward AGTCCGTGGGCATTGTGACTA 60u,3 0
Akp2 reverse CCACCTATGATCACGTGAT
BmpR1A forward ACCATTTCCAGCCCTACATC 52u,3 0
BmpR1A reverse TTTCACACACACAACCTCAC
Actin forward GTGGGCCGCTCTAGGCACCAA 60u,2 1
Actin reverse CTCTTTGATGTCACGCACGATTTC
GAPDH forward CATGTGGGCCATGAGGTCCAC 60u,2 0
GAPDH reverse TGAAGGTCGGAGTCAACGGATTTGGT
B. Cloning Primers Primer sequence (59–3 9) Anneal temp, # of cycles
Akp2 promoter forward CCGGAAGCTTAGACCGAGTTTGGAACATGC 60u,3 5
Akp2 promoter reverse CCGGCTCGAGGCTCCGTGGTAAGAGACAGG
doi:10.1371/journal.pone.0034058.t001
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Non-targeting and AKP2 siRNA pools were purchased from
Dharmacon (Lafayette, CO). EpH4-EV cells were transfected with
100 nM siRNA using DharmaFECT1 following manufacturers
instructions. Cells were harvested 24 and 48 hours post-transfec-
tion.
Luciferase Reporter Assay
EpH4-EV or EpH4-PR cells were plated in 35 mm dishes at a
density of 200,000 cells/ml in DMEM/GM. After overnight
attachment, each well was transiently transfected using FuGENE6
(Roche Applied Science) with 100 ng pRL-TK construct to
normalize for transfection efficiency and pGL3 basic vector
containing 1 mg Akp2 promoter construct. The following day,
media were replaced with DMEM/CSS in the presence or
absence of 10
28 M P. After an additional 24 hour, cells from
replicate wells were collected in 16 Reporter Lysis Buffer
(Luciferase Assay System, Promega) and assayed for luciferase
activity on a Lumat LB9507 luminometer.
Western Blot Analysis
EpH4-EV or EpH4-PR was collected, homogenized (50 mM
Tris-HCl, pH 7.5, 50 mM sodium chloride, 1 mM DTT, 1 mM
PMSF, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mg/ml pep-
statin and 0.1 mM sodium orthovanadate), sonicated, and protein
concentration determined [20]. Proteins were subjected to 10%
SDS-PAGE, transferred to Hybond nitrocellulose ECL membrane
and probed with antibodies for Alk2, Smad 8 (Santa Cruz
Biotechnologies, Santa Cruz, CA); phospho-Smad 1/5/8, phos-
pho-Smad 1/5, Smad 5 or Smad 4 (Cell Signaling, Beverly, MA),
or BMPR1A (AbCam, Cambridge, MA). Tubulin was used as
loading control (Sigma). All antibodies were used at concentrations
recommended by the manufacturers. Immunoreactivity was
determined using enhanced chemiluminescence (ECL Plus; GE
Healthcare, Pittsburgh, PA).
Preparation of Nuclear Extracts
Cells were plated as outlined above for protein isolation.
Cells were collected, resuspended, and lysed as previously
Figure 1. Progesterone Receptor stably transfected into mammary epithelial cells upregulates expression of canonical BmpR 1A
(Alk3) and non-canonical BmpR Activin-Like Kinase Receptor ActR1A (Alk2). EpH4 cells stably transfected with empty vector (EV) or the
progesterone receptor (PR) were treated+/210
28 M P for 24 hours. Total RNA was isolated and transcript abundance was evaluated via PCR for either
Alk3 (A) or Alk 2 (B). Actin was used as housekeeping gene. C) EpH4-EV and EpH4-PR cells were plated at 2.4610
5 cells/well in 6 well dishes and
treated the next day+/210
28 M P for 24 hours. Total cell lysates were analyzed via western blotting with the indicated antibodies then stripped and
re-probed for tubulin as a loading control. Representative blots of at least three experiments are shown. Graphs represent mean+/2SD of at least
three independent experiments, *P ,0.05.
doi:10.1371/journal.pone.0034058.g001
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for use.
Cross-linking to Protein A beads
Protein A-agarose beads (Santa Cruz Biotechnology) were
washed and incubated with Smad 4 antibody for 1.5 hours at
room temperature. Beads were washed twice with 0.2 M sodium
borate, pH 9, then mixed, end-over-end, with 5.2 mg/ml
dimethyl pimelimidate (Sigma) in 0.2 M sodium borate, pH 9,
for 1 hour at room temperature, washed with 0.2 M ethanolamine
(Sigma), and finally resuspended in PBS.
Nuclear extracts (1 mg) were added to the cross-linked beads
and incubated for 1.5 hours at 4uC while mixing. Beads were
washed in buffer containing protease inhibitors, collected,
resuspended in Tris-Glycine SDS Sample Buffer (Invitrogen) and
boiled. Resulting supernatant was loaded onto a gel for western
blot analysis, probed with phospho Smad 1,5,8 antibody, then
stripped and reprobed with Smad 5 antibody.
Fluorescent immunocytochemistry
EpH4-EV and EpH4-PR cells were plated on 8-well glass
chamber slides (Nunc, Rochester, NY) at either 10,000 or 20,000
cells/chamber in DMEM/GM. The following day, media were
changed to DMEM/CSS in the presence or absence of 10
28 MP .
Three hours later, cells were fixed in ice cold 100% methanol,
washed in PBS containing 0.1% Triton X-100, and blocked in 5%
normal goat serum (Jackson Laboratories, Bar Harbor, ME)
overnight at 4uC. Slides were then incubated with 1 mg/ml
phospho-Smad 1,5, 8 for 1 hour at room temperature. In all cases
no primary antibody served as the negative control. Slides were
washed four times with PBS-0.1% Triton followed by incubation
for 1 hour with red fluorescent tagged goat anti-rabbit secondary
antibody (AlexaFluor 594, 1:500, Invitrogen) in the dark. After
extensive washing with PBS containing Triton, slides were
mounted with Prolong Gold antifade reagent with DAPI
(Invitrogen). The fluorescent staining pattern was evaluated using
an Olympus BX40 fluorescence microscope (Olympus America,
Center Valley, PA).
Statistics
Images were quantified using NIH Image J64 software. The
statistical significance of the difference between groups was
determined via Student’s t-test using GraphPad InStat Software
version 3.0 b (San Diego, CA). Data are expressed as the mean 6
SD. P#0.05 was considered significant.
Results
Progesterone receptor signaling modulates the Bmp
pathway in EpH4 cells
In our previous study [6] we showed that EpH4 cells expressing
PR-A (EpH4-PR) upregulate expression of the homeobox-
Figure 2. Phospho-Smads are upregulated in progesterone receptor expressing mammary epithelial cells. A) EpH4 cells stably
transfected with empty vector (EV) or the progesterone receptor (PR) were treated+/210
28 M P for 6 hours. Total cell lysates were analyzed via
western blotting with phospho-Smad 1,5 and then stripped and re-probed for Smad 5 or tubulin. Graphs represent mean+/2SD of at least three
independent experiments, *P ,0.05. B) EpH4 parental cells were treated+/2300 ng/ml Bmp2 or Bmp4 for 6 hours. EpH4-EV and -PR cells were
treated+/210
28 M P in the presence or absence of 10 nM Noggin for 6 hours. Total cell lysates were analyzed via western blotting with phospho-
Smad 1,5, 8, Smad 8 or tubulin antibodies. The blot was stripped between assays.
doi:10.1371/journal.pone.0034058.g002
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branching on collagen gels. While our data also suggested that the
Bmp signaling pathway was involved in the process, we were
unable to demonstrate that expression of the ligands, Bmp2 and
Bmp4, was altered in the EpH4-PR cells compared to the control
cells transfected with the vector alone (EpH4-EV). To further
explore the differences in these cells, microarray analysis was
performed using Agilent whole mouse genome arrays (data not
shown). Pathway analysis suggested that a constitutively active
BmpR 1, resulting from a decrease in expression of the
phosphatase TNAP/Akp2, might be responsible for the Msx2
upregulation.
The canonical Type 1A BmpRs are Activin-like kinases 3 and 6
(Alk3 and Alk6). By semiquantitative RT-PCR, we found that
EpH4-PR cells, which constitutively express PR-A and Msx2,
upregulate BmpR1A/Alk3 mRNA relative to control EpH4-EV
cells (Fig. 1A). However, we were unable to detect BmpR1A
protein in the EpH4-PR cells by western blot analysis (data not
shown), though mammary tissue was successfully used as a positive
control for Alk3 detection. Interestingly, the non-canonical Bmp
receptor ActR-1A/Alk2 is also upregulated in the EpH4-PR cells
as determined by RT-PCR (Fig. 1B). Western blot analysis
confirmed that Alk2 protein expression is greater in EpH4-PR
cells than in the EpH4-EV cells (Fig. 1C), suggesting that this
receptor may be the main effector of PR signaling through the
Bmp receptor pathway in our EpH4-PR cells.
EpH4-PR cells or EpH4 parental cells treated with Bmp2
or Bmp4 upregulate Smad proteins and phosphorylation
To confirm that that BMP-receptor signaling is activated by
PR-signaling in EpH4 cells, we examined the levels and activation
of the Smad proteins, downstream transcription factors of the
Bmps. As shown in Fig. 2A, the levels of both phospho-Smad 1,5
and Smad 5 are significantly increased in the EpH4-PR cells
relative to EpH4-EV cells (P,0.05), even in the absence of
exogenous P. This increase is believed to be due to the ability of
PR-A to act in an unliganded manner, as observed in other studies
[22–24]. No significant increase in Smad phosphorylation was
observed upon treatment with 10
28 M P in either cell line.
Consistent with previous results [6], the phosphorylation of Smad
1,5, 8 is increased in EpH4 parental cells that have been treated
with Bmp2 or Bmp4 (Fig. 2B). Smad 8 was also upregulated in
EpH4-PR cells relative to EpH4-EV cells. While we have seen
Noggin suppress Msx2 in the EpH4-PR cells [6], addition of
Noggin (10 nM) minimally decreases phosphorylation of Smad
1,5, 8 in EpH4-EV cells, but not in PR cells. This may suggest that
Bmps binding to Bmp receptors is not required for activation of
BMP-receptor signaling in response to PR signaling.
Smads 1, 5, and 8 translocate preferentially to the
nucleus in EpH4-PR cells
When Smads 1, 5, and/or 8 are phosphorylated, they bind with
the common Smad 4 and translocate to the nucleus for initiation
of transcription [12]. To evaluate differences in amount of
activated nuclear Smads between the EpH4-EV and EpH4-PR
cells, nuclear extracts were isolated and the levels of Smads were
determined via immunoprecipitation and western analysis.
Immunoprecipitated nuclear extracts of EpH4-EV and EpH4-
PR cells with Smad 4 antibody demonstrated higher level of
phospho Smad 1,5, 8 and Smad 5 in the EpH4-PR cells (Fig. 3A).
Treatment with 10
28 M P had no significant effect above results
observed with untreated cells. The quality of the nuclear and
cytoplasmic preparations is shown in Fig. 3B. Enhanced nuclear
localization of Smads in EpH4-PR cells was further confirmed by
fluorescent immunocytochemistry (Fig. 3C).
Tissue Non-Specific Alkaline Phosphatase (Akp2) is
downregulated in EpH4-PR cells
Alk2 can be dephosphorylated by the phosphatase Akp2 [16]
and our microarray analyses showed downregulation of Akp2 in
EpH4-PR cells (data not shown). Thus, the downregulation of Akp2
may explain the upregulation of Alk2 and Smad phosphorylation
even in the presence of Noggin. To confirm this result, the
transcript abundance of Apk2 was measured in the EpH4-EV and
-PR cells and, correspondingly, Akp2 was significantly downreg-
ulated in EpH4-PR cells (P,0.05, Fig. 4A/B). Treatment with P
did not significantly alter Akp2 levels from the effects observed by
unliganded PR. Downregulation of this phosphatase suggests that
Figure 3. Smad 1, 5, 8 translocate preferentially to the nucleus
in mammary epithelial cells expressing the progesterone
receptor. EpH4 cells stably transfected with empty vector (EV) or the
progesterone receptor (PR) were quiesced by overnight incubation in
media containing charcoal stripped serum. A) Nuclear extracts were
isolated and immunoprecipitated with Smad 4 antibody that had been
cross-linked to Sepharose A beads, separated on a 10% Tris-Glycine gel,
and probed with either phospho (P) -Smad 1,5, 8 or Smad 5 antibodies.
B) Non-immunoprecipitated samples of cytosolic and nuclear fractions
from EpH4-EV and -PR cells were separated and probed with Lamin A/C
or tubulin to assure purity of nuclear preparations and equal loading,
respectively. cyto=cytosolic, nucl=nuclear. C) EpH4 cells stably
transfected with empty vector (EV) or the progesterone receptor (PR)
were treated with 10
28 M P for 24 hours, fixed and then subjected to
fluorescent immunocytochemistry. Images are representative immuno-
fluorescent staining of phospho-Smad 1, 5, 8 (red) and nuclei were
stained with DAPI (blue).
doi:10.1371/journal.pone.0034058.g003
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constitutively activated. Bmps, therefore, would not be required
for observed upregulation and phosphorylation of the Smads in
the EpH4-PR cells. We investigated whether PR acts either
directly or indirectly on the Akp2 promoter to suppress its activity.
A portion of the PR that includes the K progesterone response
element (PRE) site (21495 to 21501; [19,25]) was cloned and the
construct transfected into EpH4-EV and EpH4-PR cells. Results
demonstrate a significant downregulation of expression from the
Akp2 promoter in EpH4-PR cells (Fig. 4C, P,0.05). Treatment
with 10
28 M P further represses expression driven from the
promoter in EpH4-PR cells to 23% of the level found in similarly
treated control EpH4-EV cells. These data show that constitutive
activation of the Alk2 receptor may be the result of PR
downregulation of Akp2 promoter through the K PRE site.
Depletion of Tissue Non-Specific Alkaline Phosphatase
(Akp2) results in upregulation of Alk2 and Msx2
Our current and previous results collectively suggest that
expression of PR in mammary epithelial cells downregulates
Akp2 and that suppression of Akp2 results in an increase in Alk2
and Msx2 expression and invasive cell behavior [6]. Therefore,
siRNA-mediated knockdown of Akp2 was used to directly test
the ability of Akp2 to regulate Alk2 and Msx2 expression. Twenty-
four hours post-transient transfection using a pool of siRNA
targeting Akp2 yielded a 70% increase in Akp2 expression,
and 48-hours post-transfection a significant increase in both
Alk2 and Msx2 expression was observed (Fig. 5, P,0.05). These
data demonstrate the direct ability of Akp2 to regulate Alk2 and
Msx2.
Discussion
The conflicting roles of P in breast cancer etiology highlight the
importance of understanding the consequences of PR signaling in
mammary epithelial cells. The data presented herein, along with
other clinical in vitro and in vivo analyses suggests that activation of
P signaling leads to increased cell proliferation and events leading
to aggressive cell behaviors [6,26–30]. In the normal breast, PR-A
and -B are co-expressed in the same cells; however, in breast
cancer the PR-A: PR-B ratio is higher and PR-A is associated with
a less differentiated and more aggressive tumor [1,22]. Our data
and previous studies show that PR-A can act in an unliganded
fashion to activate gene transcription in breast cancer cells [22–
24], and unliganded PR was recently shown to attenuate taxane-
induced apoptosis [23]. PR-A expression in EpH4 cells did not
increase cell growth on plastic, but did increase branching
morphogenesis via Msx2 induction [6,21]. Our results demon-
strating PR-BMP-Smad signaling leading to Msx2 expression and
increased branching morphogenesis, but not increased prolifera-
tion is further supported by other studies showing divergent roles
of Msx2. Msx2 is a transcription factor that can induce cell
invasion as well as proliferation via Cyclin D1 [31,32]. However,
Cyclin D1 is only a target of Msx2 when it is induced by the Wnts;
Msx2 induction by the Bmps through the Smad signaling pathway
does not activate Cyclin D1 [34].
Msx2 promoter is ER and PR responsive, but does not contain
ERE, PRE, or GRE elements, suggesting that the effects of these
hormones are indirect [7]. There have been reports that PR
regulates Wnt proteins leading to Msx2 expression [8,33,34], while
other studies point to either a cooperative effect of Wnts and Bmps
[34] or to induction of Msx2 by Bmp signaling alone [31]. Our
Figure 4. TNAP/Akp2 is downregulated in progesterone receptor overexpressing mammary epithelial cells. A) RNA was isolated from
EpH4 cells stably transfected with empty vector (EV) or the progesterone receptor (PR) and transcript abundance was analyzed via semi-quantitative
PCR. B) Quantitation of transcript abundance. Data represent the mean+/2SD, *P ,0.05. C) Luciferase Assay for Akp2 promoter. EpH4-EV and EpH4-
PR cells were transfected with an Akp2 promoter-luciferase construct and with the internal control vector, pRL-TK and 24 hours after transfection,
media were removed and treated with or without 10
28 M P. Twenty-four hours later, triplicate samples were collected and analyzed. Relative
luciferase units are reported as means+/2SE. * P,0.05 between EpH4-EV and EpH4-PR cells.
doi:10.1371/journal.pone.0034058.g004
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EpH4-PR cells were exposed to the Wnt inhibitor Dkk1, but a
significant decrease was observed when the cells were treated with
the Bmp inhibitor Noggin [6], suggesting PR induces Msx2
expression via the Bmp pathway. Our results herein extend this
initial observation and confirm that P regulates the Bmp pathway
via regulation of the non-canonical BmpR type 1, Alk2.
PR cytoplasmic signaling (i.e. activation of MAPK and Src) is
transient, whereas PR function as a transcription factor may take
hours [33]. Therefore we investigated the regulation of PR
transcriptional targets 6–24 hours post exposure to P and found
that transcripts for BmpRIA/Alk3 were upregulated in EpH4-PR
cells. We were unable to detect protein in the cells, although
BmpRIA/Alk3 protein was readily detectable in mammary gland
tissue via western analysis (data not shown). Others [10] have
similarly reported difficulties in detecting the presence of
BmpRIA/Alk3 in mouse hind limb using immunohistochemistry,
suggesting a disconnect between the transcriptional and protein
regulation and/or potentially rapid degradation of BmpR1A/Alk3
protein in the tissue. Indeed, the rapid internalization and
degradation of BmpR1A has been reported in lymphocytes [35]
and presents potential alternate regulatory mechanism not covered
in the scope of the present report.
However, microarray results suggested that Alk2, a non-
canonical BmpR I, was responsible for transmitting PR signaling
in EpH4-PR cells. Our results confirm that Alk2 transcripts and
protein are indeed upregulated in EpH4-PR cells. This occurred
whether or not cells were exposed to P possibly reflecting the
known unliganded action of PR-A [22–24]. Both canonical and
non-canonical BMP signaling result in activation of Smad
proteins, therefore, we focused our studies on activation of Smads.
Thus, our results do not conclusively rule out the potential of other
BMPR regulating Msx2. However, studies demonstrating the
dominant role of Alk2 in BMP signaling suggest further studies on
Alk2 signaling are warranted. For example, it was recently shown
Figure 5. Depletion of endogenous TNAP/Akp2 results in
upregulation of Alk2 and Msx2 expression. EpH4 cells were
transfected with non-targeting or AKP2 siRNA. Twenty-four to 48 hours
post-transfection, total RNA was isolated and transcript abundance was
analyzed via semi-quantitative PCR. A) Data represent the mean+/2SD
of four independent experiments. B) Representative images from PCR
products. NTC=non-targeting control siRNA. *P,0.05.
doi:10.1371/journal.pone.0034058.g005
Figure 6. Proposed regulation of Msx2 via BMP receptor-mediated PR signaling. Progesterone receptor signaling upregulates Msx2
transcription via inhibition of the phosphatase Akp2 and upregulation of Alk2 activity, leading to phosphorylation and nuclear translocation of the
Smad transcription factor proteins.
doi:10.1371/journal.pone.0034058.g006
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epithelial cells and ovarian cancer cell lines via signaling through
Alk2/Smad4 pathway, rather than through Alk1 [36]. Addition-
ally, Endoglin, a transforming growth factor beta superfamily
auxiliary receptor, was shown to inhibit prostate cancer motility
via activation of the Alk2/Smad1 pathway [37], and BMP7
inhibition of epithelial-to-mesenchymal transition was lost when
Alk2 were knocked down in a melanoma cell line [38]. Cross-talk
between canonical and non-canonical BMP pathways may also
occur by formation of a complex involving BMPR type I, Alk2,
and Smad 1/5 similar to that observed in patients with
fibrodysplasia ossificans progressive [39]. These cooperative effects
between canonical and non-canonical BMP signaling permit
transcriptional responses on specific target genes.
Microarray data also indicated a decrease in expression of
TNAP/Akp2, an enzyme capable of hydrolyzing monophosphate
esters [40] in normal and tumor tissue [19]. Among its substrates is
phosphorylated Alk2 [16]. Our data indicate that when Akp2 is
downregulated, Alk2 is constitutively active (caAlk2) (Fig. 6). In
Xenopus, caAlk2 induces expression of ventral mesoderm markers
reminiscent of Bmp2/4 activation [13]. In our model system, PR
did not upregulate either Bmp2 or Bmp4 but upregulated Msx2
[6]. Our data show that PR downregulates Akp2 transcripts as well
as Akp2 promoter activity using a luciferase reporter system, which
may then result in a caAlk2. Further studies are being conducted
to fully analyze the Akp2 promoter and assess whether the K PRE
site is solely responsible for the repressive effect of P.
Akp2 downregulation and the resulting constitutive activation of
Alk2 may have potentially promoted the observed upregulation of
phosphorylated Smad 1,5, 8. We found that nuclear Smad 1,5, 8
were increased in EpH4-PR cells. Given that bone is a common
site of breast cancer metastasis [41–43], it is interesting that
molecules (such as BMPs, Smads, and parathyroid hormone-
related protein) involved in hormonal effects on the mammary
epithelial cells are relevant in bone development and perhaps
tumorigenesis [44].
Our mouse mammary epithelial EpH4-PR cells constitutively
overexpress Msx2 and exhibit enhanced branching [6] while
overexpression of Msx2 in NMuMG mouse mammary epithelial
cells resulted in epithelial-mesenchymal transition and enhanced
invasiveness [32]. Additionally, immunostaining for Msx2 showed
positive cells only in the infiltrating region of human infiltrating
breast carcinomas; non-infiltrating tumor cells were negative for
Msx2. In correlation with our observation that Alk2 regulates
Msx2 expression, Alk2 was shown to stimulate endothelia-to-
mesenchymal transition as a result of activating mutations in
familial syndrome fibrodysplasia ossificans progressiva, and
endothelial cells conditionally deficient for Alk2 fail to undergo
endothelia-to-mesenchymal transition during embryogenesis
[45,46]
The relationship of P, Bmp signaling and Msx2 to breast cancer
metastasis remains to be explored. Re-activation of the Akp2 gene
could be helpful in downregulating aberrant Msx2 expression in
PR+ breast cancers.
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